Outcomes Of Anterior Versus Posterior Peroral Endoscopic Myotomy 2 Years Post-Procedure: Prospective Follow-Up Results From A Randomized Clinical Trial

Background Peroral endoscopic myotomy (POEM) is considered a primary treatment modality for achalasia. It can be performed using either the anterior or posterior approach. A previous randomized clinical trial (RCT) showed that the posterior approach was noninferior to the anterior approach at 1 year post- POEM in terms of clinical success, rate of adverse event, and risk of gastroesophageal reflux disease (GERD). The aim of this post-RCT study was to compare outcomes at = 2 years post- POEM. Methods Patients who previously completed the 1- year follow-up were contacted and their Eckardt, dysphagia, and GERD questionnaire (GERDQ) scores and frequency of proton pump inhibitor use were recorded. Clinical success was defined as an Eckardt score < 3. Results 150 patients were initially randomized and 138 completed the 1-year follow-up. Of the 138, 111 (anterior group 54, posterior group 57) also completed = 2 years of follow-up, with an overall clinical success decrease from 89% to 82%. At >= 2 years post-POEM, clinical success was achieved in 46/54 (85 %) and 45/ 57 (79%) in the anterior and posterior groups, respectively (P = 0.43). A similar decrease in clinical success was noted in both groups at = 2 years ( anterior: 90% to 85 %; posterior 89% to 79 %; P = 0.47). GERDQ score was 6 (interquartile range 6 - 8; P = 0.08) in both treatment groups. Conclusions The anterior and posterior POEM techniques remained equally effective at 2 years and decreases in efficacy were similar between the two approaches over time. GERD outcomes were also similar in both groups during medium- term follow-up.